Publications

You have no permission to see this content: profileOfResearchers/view

Please sign in.

Hepatotoxicity of Piperazine Designer Drugs: Up-Regulation of Key Enzymes of Cholesterol and Lipid Biosynthesis

AuthID
P-00K-3KS

Author(s)

Arbo, MD

Melega, S

Stoeber, R

Schug, M

Rempel, E

Rahnenfuehrer, J

Godoy, P

Reif, R

Cadenas, C

Bastos, MD

Carmo, H

Hengstler, JG

Document Type

Article

Year published

2016

Published

in ARCHIVES OF TOXICOLOGY, ISSN: 0340-5761

Volume: 90, Issue: 12, Pages: 3045-3060 (16)

Indexing

Wos^®

Scopus^®

Crossref^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1007/s00204-016-1665-3

Scopus: 2-s2.0-84955611098

Wos: WOS:000387697600011

Source Identifiers

ISSN: 0340-5761

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

You have no permission to see this content: profileOfResearchers/view

Hepatotoxicity of Piperazine Designer Drugs: Up-Regulation of Key Enzymes of Cholesterol and Lipid Biosynthesis

Useful Links

Get Help

Federated Authentication (Click on the image)

You have no permission to see this content: profileOfResearchers/view

Hepatotoxicity of Piperazine Designer Drugs: Up-Regulation of Key Enzymes of Cholesterol and Lipid Biosynthesis

Useful Links

Get Help